The healthcare digital twins market, valued at around $462.6 million in 2021, is expected to grow at over 25.6% from 2022 to 2029. The industry’s growth is driven by increased demand for wearables, advancements in technology, and the growing digitization of healthcare. Although security breaches and high investment costs pose challenges, North America dominates revenue, while the Asia Pacific market is expected to grow significantly.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
